Related Experiment Video
Updated: Aug 11, 2026
A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
[A morphofunctional evaluation of the immunomodulating action of nitrosomethylurea]
Insights
Nitrosomethylurea, an antitumor agent, demonstrated immunomodulating effects in healthy and early-stage tumor-bearing animals. Low doses activated cell-mediated immunity, suggesting therapeutic potential.
Area of Science:
- Immunology
- Pharmacology
- Oncology
Background:
- The thymus and spleen are critical immune organs.
- Tumor development can impair immune function.
- Antitumor agents may possess immunomodulatory properties.
Purpose of the Study:
- To investigate the immunomodulating effects of nitrosomethylurea.
- To assess the impact of nitrosomethylurea on immune organs in healthy and tumor-bearing models.
- To determine dose-dependent effects on cell-mediated immunity.
Main Methods:
- Morphometric analysis of thymuses and spleens.
- Administration of nitrosomethylurea at high (96 mg/kg) and low (4 mg/kg) doses.
- Study of healthy animals and those bearing P 388 leukemia or Lewis carcinoma.
Main Results:
- Nitrosomethylurea exhibited immunomodulating effects across both high and low doses.
- A significant activation of cell-mediated immunity was observed in healthy animals.
- Early-stage tumor-bearing animals also showed enhanced cell-mediated immunity with low-dose nitrosomethylurea.
Conclusions:
- Nitrosomethylurea possesses dose-dependent immunomodulatory capabilities.
- Low-dose nitrosomethylurea can activate cell-mediated immunity, offering potential in cancer immunotherapy.
- Further research into nitrosomethylurea's immune-enhancing properties is warranted.
Abstract:
The thymuses and spleens from healthy and tumor-bearing (leukemia P 388 and Lewis' carcinoma) were morphometrically studied after a single administration of the antitumor agent nitrosomethylurea in doses of 96 and 4 mg/kg. When used both in the high and low doses, nitrosomethylurea had an immunomodulating effect, causing the activation of cell-mediated immunity in healthy and tumor-bearing (in early malignancy) animals when given in the small dose.
